Advisory - Ombrelle Garnier Complete Dry Mist Spray sunscreen recalled due to elevated benzene levels
OTTAWA, ON, Oct. 15, 2021 /CNW/ -
Summary
Product: Ombrelle Garnier Complete Dry Mist Spray sunscreen, SPF 30 and SPF 60 (DIN 02415313 and DIN 02415402)
Issue: Ombrelle Canada is recalling all lots due to elevated levels of benzene, which may pose serious health risks.
What to do: Stop using the recalled products. Consult a health care professional if you have used any of these products and have health concerns. Continue using other sunscreen as directed on the product label.
Issue Ombrelle Canada is recalling all lots of Ombrelle Garnier Complete Dry Mist Spray sunscreen, SPF30 and SPF 60, due to elevated levels of benzene. Frequent and long-term exposure (e.g., through the skin and by inhalation) to elevated levels of benzene may pose serious health risks.
Immediate signs of exposure to elevated levels of benzene include drowsiness, dizziness, rapid or irregular heartbeat, and headaches.
While there is no safe level of benzene, people can be exposed to benzene during everyday life by air (e.g., by inhaling car exhaust, second-hand tobacco smoke and industrial emissions), by swallowing benzene or by absorbing it through the skin (e.g., through contact with contaminated water). Long-term (over a year or more) and repeated exposure to elevated levels of benzene may lead to serious health effects, including various forms of cancer such as leukemia, anemia (low red blood cells), and bone marrow failure. These risks may increase when these products are used on children.
Health Canada emphasises that it is important that people continue to use sunscreen to protect themselves from sun damage. Ultraviolet radiation from the sun can cause cancer and other skin effects.
Health Canada recommends broad-spectrum sunscreen (one that provides protection from both ultraviolet A and ultraviolet B rays) with a Sun Protection Factor (SPF) of 30 or higher to prevent sunburn and to reduce the risk of developing skin cancer. Anyone with a known history of severe reactions to sunlight should stay out of the sun as much as possible and always use sunscreen and other sun-protective measures.
Health Canada is monitoring the company's recall. If additional safety concerns are identified, Health Canada will take appropriate action and inform Canadians.
Oragenics, Inc. , a company focused on developing unique, intranasal pharmaceuticals for the treatment of neurological disorders, today announced that it received a notice (the "Notice") from the NYSE American LLC (the "NYSE American") dated April...
Building on a successful phase one in which STChealth proved that the Universal Patient Identifier (UPI)?powered by Experian Health's Universal Identity Manager (UIM) and NCPDP Standardstm?can accurately identify patients across multiple datasets in...
StateHouse Holdings Inc. ("StateHouse" or the "Company") , a California-focused, vertically integrated cannabis company, today announced further to its press release dated April 15, 2024, that the Ontario Securities Commission (the "OSC") has denied...
Grifols, S.A. ("Grifols") (MCE: GRF, MCE: GRF.P, NASDAQ: GRFS), a global healthcare company and leading manufacturer of plasma-derived medicines, today announces the filing of its Annual Report on Form 20-F for the fiscal year ended December 31,...
Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:
On Thursday, the FDA posted a safety communication to inform the public and healthcare providers that the agency has required and...
Unifor expects to achieve the wage increases and benefit improvements awarded to Ontario OCHU-CUPE and SEIU Healthcare members by Arbitrator William Kaplan in a recent decision....